Esthesioneuroblastoma epidemiology and demographics: Difference between revisions
Simrat Sarai (talk | contribs) No edit summary |
Simrat Sarai (talk | contribs) No edit summary |
||
| Line 2: | Line 2: | ||
{{Esthesioneuroblastoma}} | {{Esthesioneuroblastoma}} | ||
{{CMG}}{{AE}}{{Simrat}} | {{CMG}}{{AE}}{{Simrat}} | ||
==Overview== | |||
The incidence of esthesioneuroblastoma is approximately 0.4 per 100,000 individuals worldwide. Esthesioneuroblastoma can present in a wide range of age groups; however, it is mostly noted in a bimodal distribution, occurring most frequently in the second and sixth decades of life. There is no racial predilection to the esthesioneuroblastoma.<ref name="ShirzadiDrazin2013">{{cite journal|last1=Shirzadi|first1=Ali S.|last2=Drazin|first2=Doniel G.|last3=Strickland|first3=Allison S.|last4=Bannykh|first4=Serguei I.|last5=Johnson|first5=J. Patrick|title=Vertebral Column Metastases from an Esthesioneuroblastoma: Chemotherapy, Radiation, and Resection for Recurrence with 15-Year Followup|journal=Case Reports in Surgery|volume=2013|year=2013|pages=1–8|issn=2090-6900|doi=10.1155/2013/107315}}</ref> | |||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
Esthesioneuroblastoma | Esthesioneuroblastoma is noted in 4 out of 10 million individuals, accounting for 5% of sinonasal and 3% of intracranial tumors.<ref name="ShirzadiDrazin2013">{{cite journal|last1=Shirzadi|first1=Ali S.|last2=Drazin|first2=Doniel G.|last3=Strickland|first3=Allison S.|last4=Bannykh|first4=Serguei I.|last5=Johnson|first5=J. Patrick|title=Vertebral Column Metastases from an Esthesioneuroblastoma: Chemotherapy, Radiation, and Resection for Recurrence with 15-Year Followup|journal=Case Reports in Surgery|volume=2013|year=2013|pages=1–8|issn=2090-6900|doi=10.1155/2013/107315}}</ref> | ||
==Incidence== | ==Incidence== | ||
The incidence of esthesioneuroblastoma was estimated to be 0.4 cases per 100,000 individuals worldwide. | The incidence of esthesioneuroblastoma was estimated to be 0.4 cases per 100,000 individuals worldwide. | ||
==Prevalence== | ==Prevalence== | ||
==Age== | ==Age== | ||
Esthesioneuroblastoma commonly affects individuals in a wide range of age groups younger than 90/older than 3 (3-90) years of age. There exists a bimodal peak of occurrence in the third and sixth decades of life. The majority of cases of esthesioneuroblastoma occur in patients between 40 and 70 years of age; the median age at diagnosis is 53 years. | Esthesioneuroblastoma commonly affects individuals in a wide range of age groups younger than 90/older than 3 (3-90) years of age. There exists a bimodal peak of occurrence in the third and sixth decades of life. The majority of cases of esthesioneuroblastoma occur in patients between 40 and 70 years of age; the median age at diagnosis is 53 years.It can present in a wide range of age groups; however, it is mostly noted in a bimodal distribution, occurring most frequently in the second and sixth decades of life. | ||
==Race== | ==Race== | ||
There is no racial predilection to the esthesioneuroblastoma. | There is no racial predilection to the esthesioneuroblastoma. | ||
==Gender== | ==Gender== | ||
There was a moderate male predominance with a 55:45 male:female ratio. | |||
Males are more commonly affected with esthesioneuroblastoma than females. The male to female ratio is approximately [1.2 > 1] to 1. | Males are more commonly affected with esthesioneuroblastoma than females. The male to female ratio is approximately [1.2 > 1] to 1.<ref name="pmid19721769">{{cite journal| author=Ward PD, Heth JA, Thompson BG, Marentette LJ| title=Esthesioneuroblastoma: Results and Outcomes of a Single Institution's Experience. | journal=Skull Base | year= 2009 | volume= 19 | issue= 2 | pages= 133-40 | pmid=19721769 | doi=10.1055/s-0028-1096195 | pmc=PMC2671304 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19721769 }} </ref><ref name="pmid15654688">{{cite journal| author=Diaz EM, Johnigan RH, Pero C, El-Naggar AK, Roberts DB, Barker JL et al.| title=Olfactory neuroblastoma: the 22-year experience at one comprehensive cancer center. | journal=Head Neck | year= 2005 | volume= 27 | issue= 2 | pages= 138-49 | pmid=15654688 | doi=10.1002/hed.20127 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15654688 }} </ref><ref name="pmid10941155">{{cite journal| author=Resto VA, Eisele DW, Forastiere A, Zahurak M, Lee DJ, Westra WH| title=Esthesioneuroblastoma: the Johns Hopkins experience. | journal=Head Neck | year= 2000 | volume= 22 | issue= 6 | pages= 550-8 | pmid=10941155 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10941155 }} </ref><ref name="pmid18798301">{{cite journal| author=Bachar G, Goldstein DP, Shah M, Tandon A, Ringash J, Pond G et al.| title=Esthesioneuroblastoma: The Princess Margaret Hospital experience. | journal=Head Neck | year= 2008 | volume= 30 | issue= 12 | pages= 1607-14 | pmid=18798301 | doi=10.1002/hed.20920 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18798301 }} </ref> | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Revision as of 16:09, 26 January 2016
|
Esthesioneuroblastoma Microchapters | |
|
Diagnosis | |
|---|---|
|
Treatment | |
|
Case Studies | |
|
Esthesioneuroblastoma epidemiology and demographics On the Web | |
|
American Roentgen Ray Society Images of Esthesioneuroblastoma epidemiology and demographics | |
|
Esthesioneuroblastoma epidemiology and demographics in the news | |
|
Blogs on Esthesioneuroblastoma epidemiology and demographics | |
|
Risk calculators and risk factors for Esthesioneuroblastoma epidemiology and demographics | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Simrat Sarai, M.D. [2]
Overview
The incidence of esthesioneuroblastoma is approximately 0.4 per 100,000 individuals worldwide. Esthesioneuroblastoma can present in a wide range of age groups; however, it is mostly noted in a bimodal distribution, occurring most frequently in the second and sixth decades of life. There is no racial predilection to the esthesioneuroblastoma.[1]
Epidemiology and Demographics
Esthesioneuroblastoma is noted in 4 out of 10 million individuals, accounting for 5% of sinonasal and 3% of intracranial tumors.[1]
Incidence
The incidence of esthesioneuroblastoma was estimated to be 0.4 cases per 100,000 individuals worldwide.
Prevalence
Age
Esthesioneuroblastoma commonly affects individuals in a wide range of age groups younger than 90/older than 3 (3-90) years of age. There exists a bimodal peak of occurrence in the third and sixth decades of life. The majority of cases of esthesioneuroblastoma occur in patients between 40 and 70 years of age; the median age at diagnosis is 53 years.It can present in a wide range of age groups; however, it is mostly noted in a bimodal distribution, occurring most frequently in the second and sixth decades of life.
Race
There is no racial predilection to the esthesioneuroblastoma.
Gender
There was a moderate male predominance with a 55:45 male:female ratio. Males are more commonly affected with esthesioneuroblastoma than females. The male to female ratio is approximately [1.2 > 1] to 1.[2][3][4][5]
References
- ↑ 1.0 1.1 Shirzadi, Ali S.; Drazin, Doniel G.; Strickland, Allison S.; Bannykh, Serguei I.; Johnson, J. Patrick (2013). "Vertebral Column Metastases from an Esthesioneuroblastoma: Chemotherapy, Radiation, and Resection for Recurrence with 15-Year Followup". Case Reports in Surgery. 2013: 1–8. doi:10.1155/2013/107315. ISSN 2090-6900.
- ↑ Ward PD, Heth JA, Thompson BG, Marentette LJ (2009). "Esthesioneuroblastoma: Results and Outcomes of a Single Institution's Experience". Skull Base. 19 (2): 133–40. doi:10.1055/s-0028-1096195. PMC 2671304. PMID 19721769.
- ↑ Diaz EM, Johnigan RH, Pero C, El-Naggar AK, Roberts DB, Barker JL; et al. (2005). "Olfactory neuroblastoma: the 22-year experience at one comprehensive cancer center". Head Neck. 27 (2): 138–49. doi:10.1002/hed.20127. PMID 15654688.
- ↑ Resto VA, Eisele DW, Forastiere A, Zahurak M, Lee DJ, Westra WH (2000). "Esthesioneuroblastoma: the Johns Hopkins experience". Head Neck. 22 (6): 550–8. PMID 10941155.
- ↑ Bachar G, Goldstein DP, Shah M, Tandon A, Ringash J, Pond G; et al. (2008). "Esthesioneuroblastoma: The Princess Margaret Hospital experience". Head Neck. 30 (12): 1607–14. doi:10.1002/hed.20920. PMID 18798301.